2022 ASAM State Advocacy Summit (VIRTUAL)

Anthony Albanese, MD, DFASAM is an Affiliations Officer with the VA Office of Academic Affiliations. He is also a Clinical Professor of Medicine and Psychiatry at the UC Davis School of Medicine. He attended college and medical school at Oral Roberts University in Tulsa Oklahoma, graduating in 1986. He did his residency in internal medicine and fellowship in gastroenterology at The St. Luke’s- Roosevelt Hospital Center in New York. During those years, he became interested in addiction medicine, working in the hospital’s methadone clinic and detoxification programs.

Under the mentorship of physicians supervising these programs, he became a member of ASAM while still in training and became a certified addictionist in 1991. He completed his hepatology fellowship at the University of Miami in 1992, and after 3 years of private practice, became the co-director of the addiction treatment program at Mount Sinai Hospital in Miami Beach, FL. As an Associate Professor of Medicine and Psychiatry at the University of Miami, he worked with the GI/Liver transplant programs, and taught in the Addiction Psychiatry fellowship program.

In 2001, he moved to Sacramento California and continued his work at the VA in gastroenterology, hepatology, and addiction medicine. Since then he has had roles as the VA Site Program Director for the UC Davis Internal Medicine and Family Medicine programs, then the Associate Chief of Staff for Education, then the Deputy Chief of Staff in the VA Northern California Healthcare System. In 2016, he accepted a national position as an Affiliations Officer with the VA Office of Academic Affiliations. He continues clinical work at the Northern California VA. His research interests have been in the medical aspects of opioids and alcohol, and intestinal changes associated with HIV infection.

Corey is an Associate Director of Advocacy and Government Relations for ASAM where he oversees the state chapters portfolio and other strategic projects. Corey holds an MPH from The George Washington University School of Public Health. 

Brian Hurley, MD, MBA, DFASAM is an addiction physician and the Director of Addiction Medicine for the Los Angeles County Department of Health Services. Brian is currently a Director at Large for the American Society of Addiction Medicine (ASAM) and will assume the position of President-Elect this April 2021. He co-chairs the Los Angeles County Department of Health Services’ Substance Use Disorders Workgroup and the SafeMedLA Medications for Addiction Treatment Action Team, and is the Clinical Director of the Addiction Treatment Starts Here programs through the Center for Care Innovations, focused on increasing the delivery of Medications for Addiction Treatment in California’s community health centers. He is the PI of two MAT Access Points projects funded by the Sierra Health Foundation, a co-PI of a TRDRP funded smoking cessation implementation project, and a co-investigator on NIDA, NIAAA, and PCORI funded addiction related implementation science grants managed through RAND. He is a member of the Motivational Interviewing Network of Trainers and regularly conducts motivational interviewing trainings throughout the United States. He is a Volunteer Assistant Clinical Professor of Addiction Medicine in the Department of Family Medicine at the UCLA David Geffen School of Medicine. He additionally serves on the American Board of Psychiatry and Neurology’s Addiction Psychiatry examination writing committee.

 Brian completed the Robert Wood Johnson Foundation Clinical Scholars Program at the University of California, Los Angeles (UCLA), and was previously a UCLA - Veterans Administration National Quality Scholar at the VA Greater Los Angeles Healthcare System. He completed a fellowship program in addiction psychiatry at New York University School of Medicine. He completed residency training at the Massachusetts General Hospital and McLean Hospital, where he was Chief Resident in Addiction Psychiatry. Brian is a former National President of the American Medical Student Association.

Professor, Department of Obstetrics and Gynecology, School of Medicine; The University of North Carolina at Chapel Hill (UNC-CH), Chapel Hill, North Carolina; Senior Advisor to UNC  

Horizons, joint appointments – Professor, Department of Psychology UNC-CH and Professor, Department of Psychiatry and Behavioral Sciences at Johns Hopkins University. Executive/Division Director of UNC  

Horizons 2013-2023; Chair, Women & Substance Use Disorders Special Interest Group, American Society of Addiction Medicine and Chair, Global Women’s Treatment and Recovery Network

Dr. Jones is a licensed psychologist and an internationally recognized expert in the development and examination of both behavioral and pharmacologic treatments for pregnant women and their children in risky life situations. She was the Division Director of UNC Horizons for a decade and in May of 2023 stepped into a Senior Advisor role for Horizons in order to take on several new national policy and international policy projects. Expertscape ranks Dr. Jones as a top world expert in neonatal abstinence syndrome and opioid-related disorders. She has received continuous National Institutes of Health funding since 1994 and has written more than 250 peer-reviewed publications. Dr. Jones has also authored two books, one on treating patients for substance use disorders and the other on comprehensive care for women who are pregnant and have substance use disorders. She also has written multiple textbook chapters on the topic of pregnancy and addiction as well as 17 courses for adult learners on topics of substance use disorder treatment (WISE, CHILD, PEERS, ALLIES etc). Dr. Jones has co-authored multiple national and international guidelines on the topic of caring for pregnant and post-pregnant people with substance use disorders and their children including those published by the WHO, SAMHSA and ASAM. She also co-authored both the women’s and children’s section of the UN International Standards for the Treatment of Drug Use Disorders and the UN guidelines on prevention and treatment for girls and women. In 2020 Dr. Jones won the ASAM R. Brinkley Smithers and Distinguished Scientist Award. In 2024 she won the MED Brady-Schuster Division 28 American Psychological Association award for lifetime achievement for contribution to addiction science. She consults for the UN and the WHO and is a member of the NIH’s HEAL multidisciplinary working group and the Advisory Committee on Research on Women's Health. Dr. Jones has been involved in over 43 projects around the world focused on improving the lives of children, women, and families.

Dr. Burnette is the Medical Director for the Center for Harm Reduction Services at Maryland Department of Health. Additional information about Dr. Burnette's work, education, and volunteer experience can be found here: https://www.linkedin.com/in/ma...

Brian Clear, MD, FASAM, is board certified in Family Medicine and Addiction Medicine, and he joined Bicycle Health in early 2020 as Medical Director and President of the Medical Provider Group. Brian earned his Doctor of Medicine (MD) from American University of the Caribbean School of Medicine and completed his residency at the University of Kentucky Family & Community Medicine Residency Program with a focus on global health. Brian’s most immediate role at Bicycle Health is to ensure clinicians have the training, resources, and support needed to provide evidence-based and high-quality care to all patients. More broadly, his focus is to improve quality of care for those experiencing problems related to opioid use. Brian is passionate about using technology to modernize the way healthcare is accessed and utilized by patients.

Prior to joining Bicycle Health, Brian served as Medical Director for the integrated treatment of opioid use disorder and primary care services with BAART Programs in San Francisco.

Beth is the Assistant Director of the Office of Public Health, within the Office of National Drug Control Policy. In this role Ms. Connolly oversees the development and implementation of public health approaches to reducing drug use and its consequences focusing on prevention, harm reduction, treatment, workforce and recovery-ready workplaces, and recovery support services.  Ms. Connolly brings more than thirty years of public health and human services experience, in both government and non-profit sectors, to ONDCP.  

Parker Baird is a policy specialist with the American Society of Addiction Medicine where he works on the state advocacy and government relations portfolio. Parker holds a BA in political science and justice and law from American University.